Head-to-head · WeighScore
Precision Telemed vs Vitara RX
By GLP-1 ScorecardUpdated
Score comparison
Vitara RX has the higher recorded score — 86/100 to 83.8/100.
Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.
Before you choose
Before comparing the headline prices, the Precision Telemed review and the Vitara RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Precision Telemed vs Youth & Soul and Primary Clinic (Direct GLP) vs Vitara RX compare each of them with another graded program, and the list of alternatives to Precision Telemed ranks the programs closest to Precision Telemed on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the RxSpan MD review covers one graded close to these two, at 84.3/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Precision Telemed | Vitara RX |
|---|---|---|
| WeighScore | 83.8/100 | 86/100 |
| Grade | B | B |
| Site position | #20 | #10 |
| Semaglutide | $149.99/month full program; $139.99/month lowest-dose maintenance; $424.99 prepaid three-month supply; confirm Autoship renewal | Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge. |
| Tirzepatide | $199 first month then $249.99/month full program; $179.99/month lowest-dose maintenance; $644.99 prepaid three-month supply; confirm renewal | Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge. |
| Coverage | Advertises all 50 states; confirm clinician and pharmacy eligibility for your address | Site lists 49 states, Alaska omitted; confirm medication-specific availability |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Published monthly and three-month quotes
- Rush Pharmacy identified by name
- Published consultation-refund terms
What to consider
- Autoship wording conflicts with FAQ
- Dispensed medication generally final sale
- Assigned pharmacy branch not independently verified
Strengths
- Named compounded semaglutide and tirzepatide offerings
- Ongoing provider messaging advertised
- Terms allow directing prescriptions to another pharmacy
What to consider
- Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
- FAQ, terms and returns pages cited earlier no longer load
- Published list omitted Alaska
- Refrigeration instructions conflict with the returns policy
- No universal lab schedule or testing price established
- Website policy descriptions leave clinical and dispensing roles unclear
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.